PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1517462
PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1517462
Global Laboratory Centrifuge Market is valued approximately at USD 1.98 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 4.21% over the forecast period 2024-2032. Laboratory centrifuges are indispensable equipment in scientific research and medical diagnostics, facilitating the separation of components based on density by employing centripetal acceleration. Widely utilized in applications such as microbiology, cellomics, proteomics, genomics, blood component separation, and diagnostics, these devices are essential for the efficient execution of various laboratory processes. Laboratory centrifuges are critical in the separation of plasma from blood, which is used in the production of therapeutic protein drugs essential for treating liver diseases. The prevalence of liver diseases, such as cirrhosis and liver cancer, which account for a significant number of global deaths, underscores the necessity for these devices. Additionally, centrifuges play a crucial role in diagnosing blood disorders like anemia and leukemia by concentrating and separating blood cells for analysis. The increasing incidence of blood cancers further propels the demand for these centrifuges.
The expansion of the laboratory centrifuge market is significantly driven by the increase in R&D activities, rising awareness about disease diagnosis in developing countries, and the surge in chronic and infectious diseases. For instance, the Joint United Nations Program on HIV and AIDS (UNAIDS) reported that 39 million people were living with HIV globally in 2022. This escalating prevalence of chronic diseases necessitates advanced diagnostic tools, thereby bolstering the demand for laboratory centrifuges. However, the high cost of laboratory centrifuge equipment and accessories presents a significant barrier to market growth. Furthermore, the rise in R&D activities in genomics, proteomics, and cellomics, along with the proliferation of academic and research institutions utilizing laboratory centrifuges, offers promising growth opportunities. Technological advancements, such as the launch of portable and miniaturized centrifuges, also contribute to market expansion. For instance, in 2021, Kubota Corporation's launch of the Benchtop Centrifuge Model S500T and Floor Standing Refrigerated Centrifuge Model S500FR exemplifies such innovations.
North America dominant the laboratory centrifuge market in terms of revenue. The region's dominance is bolstered by advanced healthcare infrastructure, robust research and development activities, and a high concentration of leading pharmaceutical and biotechnology firms. Additionally, North America benefits from significant investments in biomedical research and clinical diagnostics, driving the demand for laboratory centrifuges across academic institutions and healthcare facilities. North America is poised to maintain its leadership throughout the forecast period. This projection is supported by ongoing advancements in centrifuge technology, increasing applications in drug discovery, genomics, and proteomics research, as well as the rising prevalence of chronic diseases demanding accurate diagnostic tools. Furthermore, Asia-Pacific is expected to grow at the highest rate during the forecast period 2024-2032.